ACA
BLUE

Apis Capital Advisors’s bluebird bio BLUE Stock Holding History

Apis Capital Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$2.64M Buy
2,383
+955
+67% +$1.74M 3.65% 13
2015
Q2 		$3.11M Sell
1,428
-104
-7% -$212K 3.5% 13
2015
Q1 		$2.37M Sell
1,532
-359
-19% -$474K 3.24% 12
2014
Q4 		$2.25M Buy
+1,891
New +$1.26M 2.5% 15

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Apis Capital Advisors's BLUE Position: Q3 2015 in Review

Apis Capital Advisors increased its bluebird bio (BLUE) stake by 67% in Q3 2015, buying an estimated $1.74M and bringing the position to 2,383 shares worth $2.64M. The position accounts for 3.65% of the portfolio, ranked #13.

Apis Capital Advisors first reported a position in BLUE in Q4 2014 and has held it in 4 quarters since. The position peaked at $3.11M in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

  • Apis Capital Advisors held 2,383 shares of bluebird bio worth $2.64M as of Q3 2015.
  • Apis Capital Advisors bought 955 bluebird bio shares in Q3 2015, an estimated $1.74M.
  • bluebird bio made up 3.65% of Apis Capital Advisors's portfolio in Q3 2015, its #13 holding.
  • Apis Capital Advisors first reported a position in bluebird bio in Q4 2014 and has held it in 4 quarters since.
  • Apis Capital Advisors's bluebird bio position peaked at $3.11M in Q2 2015.
  • 192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.